9, 957-964 Thomsen RW, et al
A lapsed $250 CAD patent and expired data exclusivity opened Canada's market years before US patents expire in 2032
Both can cause nausea, vomiting, diarrhea, and constipation, especially at the start
Lillys triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial. Press release
These findings provide new insights into the tolerability trade-offs of GLP-1 therapy, particularly for women
Compounded weight management medications are custom-made formulations that address individual health factors contributing to weight gain or making weight loss more difficult